KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis

Molecular basis of mast cell disease

(2015) Erinn Soucie et al.   MOLECULAR IMMUNOLOGY

TheKITD816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease

(2014) G. Hoermann et al.   ALLERGY

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

(2014) P. Valent et al.   ALLERGY

SensitiveKITD816V mutation analysis of blood as a diagnostic test in mastocytosis

(2014) Thomas Kristensen et al.   AMERICAN JOURNAL OF HEMATOLOGY

Molecular Defects in Mastocytosis

(2014) Siham Bibi et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Pediatric Mast Cell Sarcoma of Temporal Bone With Novel L799F (2395 C>T) KIT Mutation, Mimicking Histiocytic Neoplasm

(2013) Young S. Kim et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis

(2013) Philipp Erben et al.   ANNALS OF HEMATOLOGY

SNPs inKITandKITLGgenes may be associated with oligospermia in Chinese population

(2013) Pan Cheng et al.   BIOMARKERS

Comprehensive mutational profiling in advanced systemic mastocytosis

(2013) J. Schwaab et al.   BLOOD

Primary Mast Cell Disorders in Children

(2013) Ari J. Fried et al.   CURRENT ALLERGY AND ASTHMA REPORTS

KITD816V Mutation-Positive Cell Fractions in Lesional Skin Biopsies from Adults with Systemic Mastocytosis

(2013) Thomas Kristensen et al.   DERMATOLOGY

Serum tryptase correlates with theKITD816V mutation burden in adults with indolent systemic mastocytosis

(2013) Thomas Kristensen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis

(2013) Roberta Zanotti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components

(2012) Sa A. Wang et al.   AMERICAN JOURNAL OF HEMATOLOGY

Systemic Mastocytosis With Associated Clonal Hematologic Nonmast Cell Lineage Disease: A Clinicopathologic Review

(2012) Maggie M. Stoecker et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Mast cell leukemia

(2012) S. Georgin-Lavialle et al.   BLOOD

Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor

(2012) Sophie Georgin-Lavialle et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Circulating KITD816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis

(2012) Thomas Kristensen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations

(2012) Sigurd Broesby-Olsen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Complete Response After Imatinib Mesylate Therapy in a Patient With Well-Differentiated Systemic Mastocytosis

(2012) Iván Álvarez-Twose et al.   JOURNAL OF CLINICAL ONCOLOGY

Mast Cell Sarcoma: A Rare and Aggressive Entity—Report of Two Cases and Review of the Literature

(2012) Sophie Georgin-Lavialle et al.   JOURNAL OF CLINICAL ONCOLOGY

A c-kit Mutation in Exon 18 in Familial Mastocytosis

(2012) Stefan Wöhrl et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications

(2012) Russell J H Ryan et al.   MODERN PATHOLOGY

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives

(2012) Peter Valent et al.   WIENER KLINISCHE WOCHENSCHRIFT

Dermoscopic Features of Skin Lesions in Patients With Mastocytosis

(2011) Sergio Vano-Galvan   ARCHIVES OF DERMATOLOGY

A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib

(2011) Andrzej Mital et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis

(2011) Bartosz Wasag et al.   EXPERIMENTAL HEMATOLOGY

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

(2011) Peter Valent et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Improved Detection of the KIT D816V Mutation in Patients with Systemic Mastocytosis Using a Quantitative and Highly Sensitive Real-Time qPCR Assay

(2011) Thomas Kristensen et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone

(2011) K Hussein et al.   LEUKEMIA

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis

(2011) C Teodosio et al.   LEUKEMIA

Evaluation of the WHO criteria for the classification of patients with mastocytosis

(2011) Laura Sánchez-Muñoz et al.   MODERN PATHOLOGY

Mutation D816V Alters the Internal Structure and Dynamics of c-KIT Receptor Cytoplasmic Region: Implications for Dimerization and Activation Mechanisms

(2011) Elodie Laine et al.   PLoS Computational Biology

Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations

(2010) Y. Yang et al.   BLOOD

A standardized framework for the validation and verification of clinical molecular genetic tests

(2010) Christopher J Mattocks et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

(2010) Cristina Teodosio et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V

(2010) Robert Fritsche-Polanz et al.   Molecular Oncology

Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives

(2010) Michel Arock et al.   Expert Review of Hematology

Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients

(2009) Luis Escribano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations

(2009) Christine Bodemer et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Variable presence ofKITD816Vin clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)

(2009) Karl Sotlar et al.   JOURNAL OF PATHOLOGY

Mast cells and mastocytosis

(2008) D. D. Metcalfe   BLOOD

Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation

(2008) K. M. Hoffmann et al.   BLOOD

Cutaneous Mastocytosis: A Review Focusing on the Pediatric Population

(2008) Laura D. Briley et al.   CLINICAL PEDIATRICS

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors

(2008) S Matarraz et al.   LEUKEMIA